Rare diseases
Investigational molecules
Locations
Study of felzartamab compared to placebo in adults with IgA nephropathy
PolandStudy of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo
PolandStudy of efgartigimod given by IV infusion in adolescents aged 12-17 years with chronic immune thrombocytopenia
PolandStudy of NBI-1065845 as add-on treatment to prevent depression relapse in adults with Major Depressive Disorder who responded to initial treatment
PolandStudy of raludotatug deruxtecan, ifinatamab deruxtecan and docetaxel in patients with previously treated stage IV squamous non-small cell lung cancer
PolandStudy of ifinatamab deruxtecan, raludotatug deruxtecan and docetaxel in previously treated stage IV non-small cell lung cancer patients
PolandStudy of human normal immunoglobulin and teclistamab for infection prevention in adults with multiple myeloma receiving B-cell maturation antigen therapy
PolandStudy of Rilvegostomig with Bevacizumab and Tremelimumab as First-line Treatment for Patients with Advanced Liver Cancer
PolandStudy comparing RMC-6236 and docetaxel in previously treated patients with advanced or metastatic non-small cell lung cancer who have RAS mutations
PolandStudy of mirvetuximab soravtansine dosing schedules for patients with platinum-resistant advanced ovarian, peritoneal, or fallopian tube cancer with high folate receptor expression
PolandStudy of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
PolandLong-term safety and effectiveness study of CYB003 (deupsilocin besilate) with optional additional doses for people with Major Depressive Disorder
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
